332 related articles for article (PubMed ID: 35933554)
1. The minimal FLASH sparing effect needed to compensate the increase of radiobiological damage due to hypofractionation for late-reacting tissues.
Böhlen TT; Germond JF; Bourhis J; Bailat C; Bochud F; Moeckli R
Med Phys; 2022 Dec; 49(12):7672-7682. PubMed ID: 35933554
[TBL] [Abstract][Full Text] [Related]
2. Technical Note: Break-even dose level for hypofractionated treatment schedules.
Böhlen TT; Germond JF; Bourhis J; Vozenin MC; Bailat C; Bochud F; Moeckli R
Med Phys; 2021 Nov; 48(11):7534-7540. PubMed ID: 34609744
[TBL] [Abstract][Full Text] [Related]
3. Some implications of linear-quadratic-linear radiation dose-response with regard to hypofractionation.
Astrahan M
Med Phys; 2008 Sep; 35(9):4161-72. PubMed ID: 18841869
[TBL] [Abstract][Full Text] [Related]
4. Variability of α/β ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy.
Cui M; Gao XS; Li X; Ma M; Qi X; Shibamoto Y
Radiat Oncol; 2022 Mar; 17(1):54. PubMed ID: 35303922
[TBL] [Abstract][Full Text] [Related]
5. What hypofractionated protocols should be tested for prostate cancer?
Fowler JF; Ritter MA; Chappell RJ; Brenner DJ
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1093-104. PubMed ID: 12829147
[TBL] [Abstract][Full Text] [Related]
6. Effect of reoxygenation on hypofractionated radiotherapy of prostate cancer.
Kuperman VY; Lubich LM
Med Phys; 2020 Oct; 47(10):5383-5391. PubMed ID: 32583529
[TBL] [Abstract][Full Text] [Related]
7. Obtaining organ-specific radiobiological parameters from clinical data for radiation therapy planning of head and neck cancers.
Quashie EE; Li XA; Prior P; Awan M; Schultz C; Tai A
Phys Med Biol; 2023 Dec; 68(24):. PubMed ID: 37903437
[No Abstract] [Full Text] [Related]
8. The radiobiology of hypofractionation.
Nahum AE
Clin Oncol (R Coll Radiol); 2015 May; 27(5):260-9. PubMed ID: 25797579
[TBL] [Abstract][Full Text] [Related]
9. Compatibility of the linear-quadratic formalism and biologically effective dose concept to high-dose-per-fraction irradiation in a murine tumor.
Otsuka S; Shibamoto Y; Iwata H; Murata R; Sugie C; Ito M; Ogino H
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1538-43. PubMed ID: 22115556
[TBL] [Abstract][Full Text] [Related]
10. Modern hypofractionation schedules for tangential whole breast irradiation decrease the fraction size-corrected dose to the heart.
Appelt AL; Vogelius IR; Bentzen SM
Clin Oncol (R Coll Radiol); 2013 Mar; 25(3):147-52. PubMed ID: 22910644
[TBL] [Abstract][Full Text] [Related]
11. Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data?
Santiago A; Barczyk S; Jelen U; Engenhart-Cabillic R; Wittig A
Radiat Oncol; 2016 May; 11():67. PubMed ID: 27154064
[TBL] [Abstract][Full Text] [Related]
12. Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
Shibamoto Y; Miyakawa A; Otsuka S; Iwata H
J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i76-i82. PubMed ID: 27006380
[TBL] [Abstract][Full Text] [Related]
13. Applicability of the linear-quadratic model to single and fractionated radiotherapy schedules: an experimental study.
Miyakawa A; Shibamoto Y; Otsuka S; Iwata H
J Radiat Res; 2014 May; 55(3):451-4. PubMed ID: 24351457
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Radiobiological Advantages of Hypofractionation Compared with Conventional Fractionation: Early-Passage NSCLC Cells are Less Aggressive after Hypofractionation.
Zhang H; Wan C; Huang J; Yang C; Qin Y; Lu Y; Ma J; Wu B; Xu S; Wu G; Yang K
Radiat Res; 2018 Dec; 190(6):584-595. PubMed ID: 30234458
[TBL] [Abstract][Full Text] [Related]
15. Estimation of optimum dose per fraction for high LET radiations: implications for proton radiotherapy.
Jones B; Dale RG
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1549-57. PubMed ID: 11121661
[TBL] [Abstract][Full Text] [Related]
16. Biological equivalent dose assessment of the consequences of hypofractionated radiotherapy.
Jones B; Dale RG; Finst P; Khaksar SJ
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1379-84. PubMed ID: 10889393
[TBL] [Abstract][Full Text] [Related]
17. Standard versus hypofractionated intensity-modulated radiotherapy for prostate cancer: assessing the impact on dose modulation and normal tissue effects when using patient-specific cancer biology.
Her EJ; Ebert MA; Kennedy A; Reynolds HM; Sun Y; Williams S; Haworth A
Phys Med Biol; 2021 Feb; 66(4):045007. PubMed ID: 32408293
[TBL] [Abstract][Full Text] [Related]
18. The optimal fraction size in high-dose-rate brachytherapy: dependency on tissue repair kinetics and low-dose rate.
Sminia P; Schneider CJ; Fowler JF
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):844-9. PubMed ID: 11849810
[TBL] [Abstract][Full Text] [Related]
19. Normal Tissue Sparing by FLASH as a Function of Single-Fraction Dose: A Quantitative Analysis.
Böhlen TT; Germond JF; Bourhis J; Vozenin MC; Ozsahin EM; Bochud F; Bailat C; Moeckli R
Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):1032-1044. PubMed ID: 35810988
[TBL] [Abstract][Full Text] [Related]
20. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy.
Fowler JF
Acta Oncol; 2005; 44(3):265-76. PubMed ID: 16076699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
